Skip to main content
main-content

14-02-2021 | ASCO GU 2021 | Conference coverage | Video

The role of enfortumab vedotin in earlier lines and stages of urothelial cancer

Arjun Balar discusses where enfortumab vedotin fits in the treatment paradigm of advanced urothelial cancer, focusing on earlier lines and stages (3:14).

Read transcript

2021 Genitourinary Cancers Symposium

Read news and watch expert video interviews on the most practice-influencing data from the virtual meeting

Image Credits